ClinicalTrials.gg
Drug

Methylphenidate clinical trials

Also written Ritalin, Concerta, OROS MPH and PRC-063.

studies test it
324
open now
36
in phase 3
76
first study started
1997

How each study uses Methylphenidate is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Methylphenidate studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
5 Dec 1955 · RITALIN · NDA 010187 (FDA, Drugs@FDA)
European Union
28 Feb 2025 · Tuzulby · EMEA/H/C/005975 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Methylphenidate
156
methylphenidate hydrochloride
29
MPH
17
Methylphenidate Transdermal System
12
Methylphenidate HCl
8

Brand

Ritalin
80
Concerta
54
Daytrana
11
Foquest
4
Methylin
3
Jornay PM
3
Adhansia XR
3
Aptensio XR
2

Development codes

PRC-063
2
SPD544
1

Other names

OROS MPH
3

Studies by the year they started

318 studies that test it; most in 2014 (26); 2 more planned to start later

Studies that test Methylphenidate, by start year
YearStudies
19972
19984
19994
20002
20016
20028
200311
200413
200512
200619
200721
200816
200911
201017
201110
201214
201318
201426
201510
201612
20178
201813
201911
20206
20216
20227
202311
20249
20254
20267

By phase

A phase 1/2 study counts in both.

Early Phase 1
11
Phase 1
34
Phase 2
57
Phase 3
76
Phase 4
114
No phase
49

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 57 · Other 267

Massachusetts General Hospital (16) · M.D. Anderson Cancer Center (10) · Rhodes Pharmaceuticals, L.P. (9) · Noven Therapeutics (8) · Shalvata Mental Health Center (7) · Icahn School of Medicine at Mount Sinai (6) · Children's Hospital Medical Center, Cincinnati (6) · New York State Psychiatric Institute (6)

Often tested with

Tested in the same studies.

Atomoxetine (11) · Modafinil (10) · N-Methyl-3,4-methylenedioxyamphetamine (4) · Reboxetine (4) · Guanfacine (4) · Lisdexamfetamine (4) · Caffeine (4) · Carbidopa, levodopa drug combination (3)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 9, 2 in phase 3

Studies that test Methylphenidate, phase 3 first.

Studies

Open first, then newest update. How each study uses Methylphenidate is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 324

See all 324 studies that test Methylphenidate →

Given beside what is tested · 16 — Methylphenidate is usual care or a partner of the new treatment
As the comparator · 20 — what is tested is compared with Methylphenidate

What changed recently

From the registry's own updates since Oct 20, 2026.

Codes

What other systems call Methylphenidate · ClinicalTrials.gg INT007821

  • MeSH (NLM) D008774MethylphenidateConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 207ZZ9QZ49METHYLPHENIDATEConfirmed FDA, NLM, Wikidata
  • RxNorm 6901Confirmed FDA, Wikidata
  • Wikidata Q422112methylphenidateConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C62045MethylphenidateOne source FDA
  • DrugBank DB00422One source Wikidata

Also registered as methylphenidate hydrochloride (UNII 4B3SC438HI).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.